Kyverna Therapeutics, Inc. (KYTX) Earning

$2.81

$0.02 (-0.53%)
Last update: 01:00 PM EST
Day's range
$2.76
Day's range
$2.97
KYTX Earnings Estimates and Actuals by Quarter$0$0-$0.5-$0.5-$1-$1-$1.5-$1.5Q2 2024Q2 2024Q3 2024Q3 2024Q4 2024Q4 2024Q1 2025Q1 2025Q2 2025Q2 2025Q3 2025Q3 2025Q4 2025Q4 2025Q1 2026Q1 2026Q2 2026Q2 2026Q3 2026Q3 2026Q4 2026Q4 2026
Actual EPS
Download SVG
Download PNG
Download CSV

Kyverna Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 2 -$1.28 -$0.95 -$1.13
Q2 2025 5 -$1.18 -$0.87 -$1.04
Q3 2025 2 -$0.92 -$0.92 -$0.92
Q4 2025 2 -$0.80 -$0.80 -$0.80
Q1 2026 1 -$0.75 -$0.75 -$0.75
Q2 2026 1 -$0.77 -$0.77 -$0.77
Q3 2026 1 -$0.81 -$0.81 -$0.81
Q4 2026 1 -$0.74 -$0.74 -$0.74

Kyverna Therapeutics, Inc. Earnings Date And Information

Kyverna Therapeutics, Inc. last posted its earnings results on Tuesday, May 13th, 2025. The company reported $-1.03 earnings per share for the quarter, topping analysts' consensus estimates of $-1.21 by $0.18. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Kyverna Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-3.33 diluted earnings per share) and currently has a price-to-earnings ratio of -0.84. Kyverna Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based on prior year's report dates.

Kyverna Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
05/13/2025 Q1 2025 -$1.21 -$1.03 0.18 $0 $0
03/27/2025 Q4 2024 -$0.87 -$0.92 -0.05 $0 $0
11/13/2024 Q3 2024 -$0.77 -$0.80 -0.03 $3.75 M $0
08/12/2024 Q2 2024 -$0.70 -$0.67 0.03 $0 $0
05/14/2024 Q1 2024 -$0.88 -$1.12 -0.24 N/A $0
03/26/2024 Q4 2023 N/A -$0.48 N/A N/A $0
09/29/2023 Q3 2023 N/A -$0.36 N/A N/A $0
06/30/2023 Q2 2023 N/A -$0.30 N/A N/A $0
03/30/2023 Q1 2023 N/A -$0.43 N/A N/A $0
12/30/2022 Q4 2022 N/A -$0.20 N/A N/A $282.00 K

Kyverna Therapeutics, Inc. Earnings: FAQ's

Kyverna Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based offlast year's report dates.

In the previous quarter, Kyverna Therapeutics, Inc. (:KYTX) reported $-1.03 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.21 by $0.18.

The conference call for Kyverna Therapeutics, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Kyverna Therapeutics, Inc.'s latest earnings report can be read online.

Kyverna Therapeutics, Inc. (:KYTX) has a recorded net income of $-127,477,000.Kyverna Therapeutics, Inc. has generated $-3.33 earnings per share over the last four quarters.

Kyverna Therapeutics, Inc. (:KYTX) has a price-to-earnings ratio of -0.84 and price/earnings-to-growth ratio is -0.33.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED